$ABBV Recent News Paulson takes stake in Abbvie, adds

New Post Public Reply Private Reply Replies (0) Message Board

Nov 15, 2014 at 2:33 PM

$ABBV Recent News

Paulson takes stake in Abbvie, adds to Shire holdings 6:46 p.m. Nov. 14, 2014 - MarketWatch
Obama considering Lazard banker for Treasury post 4:20 p.m. Nov. 12, 2014 - Victoria McGrane
77 stocks in the S&P 500 Index rise to new highs 10:50 a.m. Nov. 12, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
S&P 500, Dow close at record levels 4:16 p.m. Oct. 31, 2014 - Barbara Kollmeyer
Apple rallies to record high; LinkedIn jumps 11:05 a.m. Oct. 31, 2014 - Sue Chang
AbbVie stock up 3.6% at $63.38 9:32 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie shares up 4% in premarket trade 8:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie raises outlook as profit, sales beat 8:26 a.m. Oct. 31, 2014 - MarketWatch.com
AbbVie shares up 2% as profit, sales beat estimates 8:00 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie prior FY EPS outlook was $3.06 to $3.16 7:54 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie's stock gains 2.2% premarket after Q3 results beat expectations 7:53 a.m. Oct. 31, 2014 - Tomi Kilgore
AbbVie raises FY EPS outlook to $3.25 to $3.27 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet revenue consensus $4.831 bln 7:53 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 FactSet EPS consensus 77 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 revenue $5.019 bln, up 7.85 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 adj. EPS 89 cents 7:52 a.m. Oct. 31, 2014 - Ciara Linnane
AbbVie Q3 EPS 31 cents vs 60 cents 7:51 a.m. Oct. 31, 2014 - Ciara Linnane
Mylan 3Q profit soars as revenue tops estimates 5:19 p.m. Oct. 30, 2014 - MarketWatch.com
12 highest-yielding ‘dividend aristocrat’ stocks 10:38 a.m. Oct. 30, 2014 - Philip van Doorn

7 Aristocrat Dividend Dogs Hit 5% To 12.75% November Upsides 6:10 p.m. Nov. 14, 2014 - Seeking Alpha
Deutsche Bank Initiates Coverage On AbbVie 11:08 a.m. Nov. 14, 2014 - benzinga.com
Top Analyst Upgrades and Downgrades: Harley-Davidson, Lululemon, Nike, SunPower, Walmart and More 7:58 a.m. Nov. 14, 2014 - 247WallSt.com
Deutsche Bank Initiates AbbVie With Buy 7:10 a.m. Nov. 14, 2014 - benzinga.com
The Post AASLD Annual Meeting Hepatitis C Landscape 6:15 a.m. Nov. 14, 2014 - Seeking Alpha
EU Probing Apple Inc. (AAPL), Starbucks (SBUX) Tax Deals 6:06 a.m. Nov. 14, 2014 - InvestorPlace.com
If Gilead Has The Ace, Is AbbVie Holding The Big Joker? 2:55 a.m. Nov. 14, 2014 - Seeking Alpha
Hedge Fund Tales - Or What Is Wrong With Merger Arbitrage 12:57 p.m. Nov. 13, 2014 - TheStreet.com
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic 8:38 a.m. Nov. 13, 2014 - 247WallSt.com
10 Must-Own Stocks With Great Earnings, Sales and Guidance 12:15 a.m. Nov. 13, 2014 - InvestorPlace.com
Obama to Nominate Lazard Banker for a Top Treasury Post 6:10 p.m. Nov. 12, 2014 - The Wall Street Journal Interactive Edition
Achillion Pharmaceuticals: Still Bullish, But Taking Profits 5:06 p.m. Nov. 12, 2014 - Seeking Alpha
Gilead Reports Promising Data on its HCV Drug Harvoni - Analyst Blog 5:00 p.m. Nov. 12, 2014 - Zacks.com
Gilead Sciences Gets Ambushed By The Patent Troll, AbbVie 3:25 p.m. Nov. 12, 2014 - Seeking Alpha
Regeneron/Sanofi Announce Positive Dupilumab Study Data - Analyst Blog 11:00 a.m. Nov. 12, 2014 - Zacks.com
Biotech Stock Roundup: Gilead, AbbVie Score at Liver Meeting, Dendreon Files for Bankruptcy - Analyst Blog 8:48 a.m. Nov. 12, 2014 - Zacks.com
Earnings Triple Plays 2:54 a.m. Nov. 12, 2014 - Seeking Alpha
Bristol-Myers Gives Updates on HCV Candidate Daclatasvir - Analyst Blog 6:41 p.m. Nov. 11, 2014 - Zacks.com
Galapagos - AbbVie's Best Bet For Staying Market Leader In Rheumatoid Arthritis Post Humira? 3:45 p.m. Nov. 11, 2014 - Seeking Alpha
Re-Examining My Bullish Thesis On Walgreen 2:04 p.m. Nov. 11, 2014 - Seeking Alpha

AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology 4:48 p.m. Nov. 14, 2014 - PR Newswire - PRF
AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014 9:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014 8:00 a.m. Nov. 11, 2014 - PR Newswire - PRF
Infinity Reports Third Quarter 2014 Financial Results and Provides Company Update 4:01 p.m. Nov. 6, 2014 - BusinessWire - BZX
Technical Notes Covering Pharma Equities - AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Eli Lilly, and Teva Pharma Industries 8:50 a.m. Nov. 6, 2014 - PR Newswire - PRF
ABBVIE (ABBV) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty 8:03 a.m. Nov. 5, 2014 - BusinessWire - BZX
AbbVie to Present at Credit Suisse 2014 Healthcare Conference 8:00 a.m. Nov. 5, 2014 - PR Newswire - PRF
ABBVIE INC. ALERT -- Andrews & Springer LLC is Investigating AbbVie Inc. for Potential Securities Fraud and Breach of Fiduciary Duty 8:09 a.m. Nov. 3, 2014 - GlobeNewswire
Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) 7:05 a.m. Nov. 3, 2014 - GlobeNewswire
CMK Select Recognized as Women's Business Enterprise 10:45 a.m. Oct. 31, 2014 - Marketwired
AbbVie Reports Third-Quarter 2014 Financial Results 7:49 a.m. Oct. 31, 2014 - PR Newswire - PRF
If You Purchased Shire plc American Depository Receipts ("ADRs"

During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm 8:38 a.m. Oct. 29, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF
AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year 8:00 a.m. Oct. 23, 2014 - PR Newswire - PRF
Merger Deal Updates, Dividend, Dispute Settlement, Regulatory Application Submission, and Preliminary Results - Research Reports on Shire, Johnson & Johnson, Merck, Amgen and HCA 9:00 a.m. Oct. 21, 2014 - PR Newswire - PRF
AbbVie Announces New $5 Billion Stock Repurchase Program and Increases Dividend 5:31 p.m. Oct. 20, 2014 - PR Newswire - PRF
Announcement Of Termination Of Proposed AbbVie And Shire Transaction 5:12 p.m. Oct. 20, 2014 - PR Newswire - PRF
Acquisition Updates, Drug Approval, Drug Development Discontinuation, and Contract Update - Research Reports on AbbVie, Gilead, Pfizer, Lilly and Aetna 8:35 a.m. Oct. 20, 2014 - PR Newswire - PRF
AbbVie Board Recommends Stockholders Vote Against Shire Transaction 11:53 p.m. Oct. 15, 2014 - PR Newswire - PRF
Announcement Of Notice To Shire Of AbbVie Board Intention To Reconsider Recommendation 7:44 p.m. Oct. 14, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CallRail's New Insight Tool: Navigating the Competitive Landscape

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...

Cat Financial Shows Solid Q3 Growth Amid Challenges

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

NeuroSense's Phase 3 Strategies for PrimeC Unveiled

How NeuroSense Is Poised to Tackle ALS Treatment Picture this: a room full of people holding their breath, hoping that NeuroSense can deliver the breakthrough they’ve been inching toward. It’s the kind of moment that gives you goosebumps if you've been sloggin' through the biotech trenches. NeuroSense’s pitch at NEALS is more than just a dog and pony show—it's a...

Why Haunted Attractions Keep Us Coming Back for Fear

Welcome to Fear Incarnated Ah, Kansas City. More than just jazz and barbeque. You’ve got these infamous haunted houses that turn every horror flick into a mere Saturday morning cartoon. Enter Edge of Hell and Beast Haunted Attraction. Two horrifying museums of fear that somehow lure us like flies to sugar from miles away. What's the secret sauce? Well, that’s half the...

Scientology Aids in Huge Meal Effort After Hurricane

Weathering the Storm and Feeding the Survivors Alright, so here's the thing—when a hurricane hits, it doesn't just mess up your weekend plans. We're talking about massive upheaval, like making more than 900,000 folks powerless in the Florida Panhandle. No electricity means no cooking, and in comes the disaster crew to save the day. Enter the Churches of Scientology...

Viedoc and Bioforum Unite: Clinical Data Innovation

Revamping Clinical Trials with Data Integration It doesn't take a Wall Street wizard to understand that in today's research game, having data is only half the battle—using it effectively is where the rubber meets the road. Enter Viedoc and Bioforum, two names that are well-acquainted with the grind of the clinical research world. These seasoned pros have joined forces,...

DayOne's Bold Energy Moves With Sembcorp for Asia Growth

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Bravo Loans Bridge Gaps in Healthcare Real Estate

Mezzanine Financing: A Vital Tool for Healthcare Owners Bravo Property Trust is throwing a lifeline to operators in the healthcare sector and beyond with their mezzanine loans aiming right between the eyes of the financing gap. This isn't just some loan for fun. It's a full-on financial tool designed to give some breathing room to folks owning or operating skilled nursing...

Collective Scoops $100M, Powers Solopreneur's Financial Might

Picture This: A Solo Businessman in 2026 Imagine a lone ranger running a show that used to take an entire office. That’s the magic happening with roughly 30 million solo businesses in the U.S. today, and folks, the numbers are staggering. As these one-man-bands push past clunky old systems, a big name is lighting the way: Collective. They raised a hefty $100 million to...

Tiny Fish Revolutionizes Vertebrate Gene Studies

From Small Fish to Big Discoveries: Meet Danionella cerebrum Who would've thought a diminutive fish with a see-through body would give a jolt to the study of vertebrate genomes? Thanks to Danionella cerebrum, researchers at the Whitehead Institute have created the very first complete whole-body single-cell atlas of an adult vertebrate. Forget the Wall Street clamor for a...